GoAI
Get started
Guardian Pharmacy Services, Inc. logo

Guardian Pharmacy Services, Inc.

GRDN

NYSEHealthcareMedical - Care Facilities

Open in GoAI

Previous close

$37.93

+$0.45 · +1.20%

Aug 21, 4:00 PM ET

GRDN company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

46

Fair Value

Momentum

61

Gaining

Sentiment

63

Bullish

Risk resilience

69

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Guardian Pharmacy Services, Inc. operates as a pharmaceutical service provider, delivering an extensive array of tech-driven solutions. These services are specifically crafted to enhance the care of residents within long-term health care facilities (LTCFs) across the United States. The company specializes in offering personalized clinical assistance, efficient drug distribution, and comprehensive administrative support. These provisions are particularly beneficial for individuals in less acute long-term care environments, such as assisted living communities, behavioral health centers, and group homes. To bolster its operations, the company offers Guardian Compass, a platform that generates insightful dashboards from its extensive data warehouse. This tool enables its network of local pharmacies to effectively strategize, monitor performance, and refine their business processes. Furthermore, Guardian Pharmacy Services develops dedicated GuardianShield Programs for LTCFs. The company was established in 2003 and is based in Atlanta, Georgia.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
US
CEO
Fred Burke
Listed since
Sep 26, 2024
Employees
3,600

Market position

Day range

Current $37.93

52-week range

Current $37.93

Open
$37.635
Previous close
$37.48
Volume
223.06K
0.56× average
Average volume
395.31K
Average daily volume
Market cap
2.4B USD
Beta
0.1
Market reference 1
50-day average
$40.5098
-6.37% below average
200-day average
$35.3369
+7.34% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
1.85B USD
P/E (TTM)
36.12×
P/B (TTM)
9.78×
P/S (TTM)
1.64×
EV / EBITDA
19.17×
Earnings yield
2.62%
Free cash flow yield
4.30%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
21.63%
Operating margin
6.27%
Net margin
4.50%
Return on equity
23.92%
Return on assets
11.93%
Return on invested capital
22.88%

Financial health

Debt / equity
0.14×
Current ratio
1.38×
Altman Z-score
12.36
Piotroski F-score
6 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends23%12%1%-10%Gross margin, FY2021: 20.36%Gross margin, FY2022: 20.45%Gross margin, FY2023: 19.91%Gross margin, FY2024: 19.89%Gross margin, FY2025: 19.47%Operating margin, FY2021: 3.81%Operating margin, FY2022: 5.72%Operating margin, FY2023: 3.91%Operating margin, FY2024: -5.12%Operating margin, FY2025: 6.14%Net margin, FY2021: 2.06%Net margin, FY2022: 3.90%Net margin, FY2023: 2.28%Net margin, FY2024: -7.11%Net margin, FY2025: 3.40%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 20.36%. Gross margin FY2022 20.45%. Gross margin FY2023 19.91%. Gross margin FY2024 19.89%. Gross margin FY2025 19.47%. Operating margin FY2021 3.81%. Operating margin FY2022 5.72%. Operating margin FY2023 3.91%. Operating margin FY2024 -5.12%. Operating margin FY2025 6.14%. Net margin FY2021 2.06%. Net margin FY2022 3.90%. Net margin FY2023 2.28%. Net margin FY2024 -7.11%. Net margin FY2025 3.40%.

Income trends

Revenue

1.45B USD+17.93%

Operating income

88.91M USD+151.83M USD

Net income

49.22M USD+136.51M USD
Income trends across reported periods1.6B USD987.89M USD373.5M USD−240.88M USDRevenue, FY2021: 792.07M USDRevenue, FY2022: 908.91M USDRevenue, FY2023: 1.05B USDRevenue, FY2024: 1.23B USDRevenue, FY2025: 1.45B USDOperating income, FY2021: 30.15M USDOperating income, FY2022: 51.99M USDOperating income, FY2023: 40.95M USDOperating income, FY2024: −62.92M USDOperating income, FY2025: 88.91M USDNet income, FY2021: 16.31M USDNet income, FY2022: 35.42M USDNet income, FY2023: 23.9M USDNet income, FY2024: −87.29M USDNet income, FY2025: 49.22M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 792.07M USD. Revenue FY2022 908.91M USD. Revenue FY2023 1.05B USD. Revenue FY2024 1.23B USD. Revenue FY2025 1.45B USD. Operating income FY2021 30.15M USD. Operating income FY2022 51.99M USD. Operating income FY2023 40.95M USD. Operating income FY2024 −62.92M USD. Operating income FY2025 88.91M USD. Net income FY2021 16.31M USD. Net income FY2022 35.42M USD. Net income FY2023 23.9M USD. Net income FY2024 −87.29M USD. Net income FY2025 49.22M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue1.45B USD1.23B USD1.05B USD908.91M USD792.07M USD
Cost of goods sold1.17B USD984.04M USD837.88M USD723.04M USD630.81M USD
Gross profit282.04M USD244.37M USD208.31M USD185.87M USD161.27M USD
Selling, general, and administrative193.13M USD307.29M USD167.36M USD133.88M USD131.12M USD
Operating expenses193.13M USD307.29M USD167.36M USD133.88M USD131.12M USD
Interest expense665K USD3.28M USD2.86M USD1.93M USD1.64M USD
Depreciation and amortization22.34M USD19.77M USD18.23M USD16.56M USD16.53M USD
Operating income88.91M USD−62.92M USD40.95M USD51.99M USD30.15M USD
Net income49.22M USD−87.29M USD23.9M USD35.42M USD16.31M USD

Company facts updated Aug 24, 2026.

Earnings

Latest fiscal-year EPS
0.78
FY2025
Latest fiscal-year revenue
1.45B USD
FY2025 · +17.93% year over year
Next fiscal-year EPS consensus
1.3
FY2026 · 4 analysts
Next fiscal-year revenue consensus
1.44B USD
FY2026 · 4 analysts

Annual EPS trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual EPS trend2.190.75-0.69-2.13FY21FY22FY23FY24FY25FY26FY27FY28

Annual revenue trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual revenue trend1.78B1.42B1.06B702.21MFY21FY22FY23FY24FY25FY26FY27FY28

GRDN peers

Eli Lilly and Company logo

LLY

Eli Lilly and Company

$1,254.77

+0.83%

Johnson & Johnson logo

JNJ

Johnson & Johnson

$270.24

+1.07%

AbbVie Inc. logo

ABBV

AbbVie Inc.

$265.01

+1.21%

Merck & Co., Inc. logo

MRK

Merck & Co., Inc.

$152.55

+2.39%

UnitedHealth Group Incorporated logo

UNH

UnitedHealth Group Incorporated

$390.11

+1.37%

Novartis AG logo

NVS

Novartis AG

$158.86

+1.68%

ETFs holding GRDN

Funds reporting this stock among their holdings, ordered by reported position size.

Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
40.65M
Weight
0.00%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
iShares Russell 2000 ETF logoiShares Russell 2000 ETFIWM
Market value
17.45M
Weight
0.02%
AUM
81.62B USD
Expense ratio
0.19%
Price / 1D
$299.96+0.77%
Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
12.65M
Weight
0.01%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$245.53+0.82%
First Trust Small Cap Growth AlphaDEX Fund logoFirst Trust Small Cap Growth AlphaDEX FundFYC
Market value
6.69M
Weight
0.47%
AUM
1.42B USD
Expense ratio
0.70%
Price / 1D
$122+0.71%
First Trust US Equity Opportunities ETF logoFirst Trust US Equity Opportunities ETFFPX
Market value
6.45M
Weight
0.43%
AUM
1.51B USD
Expense ratio
0.57%
Price / 1D
$183.88+0.42%
iShares Russell 2000 Growth ETF logoiShares Russell 2000 Growth ETFIWO
Market value
6.44M
Weight
0.04%
AUM
15.16B USD
Expense ratio
0.24%
Price / 1D
$387.37+1.24%
Dimensional - US Small Cap ETF logoDimensional - US Small Cap ETFDFAS
Market value
4.54M
Weight
0.03%
AUM
15.92B USD
Expense ratio
0.26%
Price / 1D
$83.02+0.73%
Vanguard Russell 2000 ETF logoVanguard Russell 2000 ETFVTWO
Market value
4.01M
Weight
0.02%
AUM
17.4B USD
Expense ratio
0.06%
Price / 1D
$121.25+0.74%

Continue in GoAI

Research GRDN

research.disclaimer